Kinase inhibitors with redox and anti-inflammatory activities

Nina Ivanovska, Luciano Saso, Petya Dimitrov1

  • 1Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, 26 Georgi Bonchev str., 1113 Sofia, Bulgaria. petya_dimitrova@web.de.

Insights

Inflammation involves nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling, which is sensitive to cellular changes. Targeting ROS-sensitive kinases in NF-κB pathways can impact cell survival and metabolism, crucial for drug efficacy.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Inflammatory immune responses are linked to nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathways.
  • Intracellular molecules within the NF-κB pathway are sensitive to microenvironmental changes, including redox state and proliferation.
  • Inflammation-induced alterations activate non-canonical and atypical NF-κB signaling, interacting with neddylation, cell cycle, and DNA repair pathways.

Purpose of the Study:

  • To review reactive oxygen species (ROS)-sensitive kinases within the NF-κB pathway.
  • To discuss the effects of small kinase inhibitors on these ROS-sensitive kinases.
  • To highlight the implications of targeting redox-sensitive molecules in NF-κB cascades for cell survival, metabolism, and drug efficacy.

Main Methods:

  • Literature review of studies on NF-κB signaling, inflammation, and kinase inhibitors.
  • Analysis of the role of ROS-sensitive kinases in inflammatory pathways.
  • Examination of the impact of kinase inhibition on cellular processes.

Main Results:

  • NF-κB pathway activation is influenced by cellular redox state and other microenvironmental factors.
  • ROS-sensitive kinases play a key role in inflammatory NF-κB signaling.
  • Selective inhibition of these kinases can modulate cell survival and metabolism.

Conclusions:

  • Targeting redox sensor molecules in inflammatory NF-κB cascades offers therapeutic potential.
  • Understanding these interactions is vital for evaluating drug efficacy and side effects in clinical settings.
  • The interplay between NF-κB signaling, redox state, and cellular processes presents a critical area for further research.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.8K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.9K
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.1K